Barclays’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.26M Buy
2025
Q3
$642K Buy
2025
Q2
$284K Buy
2025
Q1
$142K Sell
2024
Q4
$285K Buy
2024
Q3
$328K Buy
2024
Q2
$98.2K Sell
2024
Q1
$193K Sell
2023
Q4
$481K Sell
2023
Q3
$621K Buy
2023
Q2
$115K Buy
2023
Q1
$65.6K Buy
2022
Q4
$51.8K Buy